CareDx Non-GAAP EPS of $0.12 misses by $0.11, revenue of $108.4M beats by $5.66M
Source: SeekingAlpha
2026-02-24 16:03:04 ET
More on CareDx
- CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy - Slideshow
- CareDx, Inc. (CDNA) Discusses AlloHeme Clinical Validation Data Review and Launch Timeline in AML and MDS Post-Cell Therapy Transcript
- CareDX Has Reached An Inflection Point, But Regulatory Risks Remain (Upgrade)
- CareDx Q4 2025 Earnings Preview
- CareDx announces preliminary fourth quarter and full year 2025 financial results
Read the full article on Seeking Alpha
For further details see:
CareDx Non-GAAP EPS of $0.12 misses by $0.11, revenue of $108.4M beats by $5.66M
CareDx Inc.
NASDAQ: CDNA
CDNA Trading
-3.24% G/L:
$16.73 Last:
186,222 Volume:
$16.98 Open:
CDNA Latest News
March 05, 2026 04:01:00 pm
CareDx Announces VANTx(TM), an AI?Powered Clinical Data & Analytics Platform Built on CareDx's Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
February 24, 2026 05:15:00 pm
CareDx Announces Appointment of Keith Kennedy as Chief Operating Officer and Chief Financial Officer
CDNA Stock Data
$1,055,912,079
49,169,603
1.47%
62
N/A
Medical Diagnostics & Screening
Healthcare
US
Brisbane
